Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252915
Status:
COMPLETED
Last Update Posted:
2011-05-26
First Post:
2005-11-14
Brief Title:
Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor GM-CSF in Patients With Severe Sepsis and Septic Shock
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor GM-CSF in Patients With Severe Sepsis and Septic Shock a Prospective Randomised Double-blind Placebo-controlled Study
Status:
COMPLETED
Status Verified Date:
2009-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There is basic science evidence that GM-CSF reconstructs cellular immunity in septic patients In this prospective randomised double-blind placebo-controlled trial we investigate whether this can be achieved in patients with severe sepsis and septic shock
Detailed Description:
GM-CSF reconstructs cellular immunity in septic patients In this prospective randomised double-blind placebo-controlled trial we investigate whether this can be achieved in patinets with severe sepsis and septic shock
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None